{"id":1608361,"date":"2025-04-03T02:46:28","date_gmt":"2025-04-03T04:46:28","guid":{"rendered":"https:\/\/teknomers.com\/fr\/aardvark-therapeutics-a-presente-les-resultats-du-dernier-trimestre\/"},"modified":"2025-04-03T02:46:32","modified_gmt":"2025-04-03T04:46:32","slug":"aardvark-therapeutics-a-presente-les-resultats-du-dernier-trimestre","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/aardvark-therapeutics-a-presente-les-resultats-du-dernier-trimestre\/","title":{"rendered":"Aardvark Therapeutics a pr\u00e9sent\u00e9 les r\u00e9sultats du dernier trimestre"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p>Aardvark Therapeutics a comment\u00e9 le 31 mars 2025 sur les r\u00e9sultats commerciaux du trimestre le 31 d\u00e9cembre 2024.<\/p>\n<p>Aardvark Therapeutics a g\u00e9n\u00e9r\u00e9 une perte de 0,40 $ par action au cours du r\u00e9cent trimestre annuel. L&#8217;ann\u00e9e pr\u00e9c\u00e9dente, il \u00e9tait de -0,100 USD par action.<\/p>\n<p>Le r\u00e9sultat par action a \u00e9t\u00e9 n\u00e9gatif pour l&#8217;ann\u00e9e globale. La perte par papier \u00e9tait estim\u00e9e \u00e0 0,950 $. L&#8217;ann\u00e9e pr\u00e9c\u00e9dente -0,340 USD par action avait \u00e9t\u00e9 dans les livres.<\/p>\n<p>\u00c9diteur finance.net<\/p>\n<\/div>\n<p>Soit dit en passant: les actions am\u00e9ricaines peuvent m\u00eame \u00eatre n\u00e9goci\u00e9es sur finance.net z\u00e9ro jusqu&#8217;\u00e0 23 h. (sans frais de commande, plus les \u00e9carts). <a rel=\"nofollow noopener\" href=\"https:\/\/g.finanzen.net\/zero-fnet_251-news-us-aktien-langer-us-handel\" class=\"font-color-de-azure-blue\" target=\"_blank\">Ouvrez le d\u00e9p\u00f4t maintenant gratuitement<\/a> Et recevez un stock gratuit en cadeau.<\/p>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/aardvark-therapeutics-stellte-ergebnisse-des-abgelaufenen-quartals-vor-14365833\" rel=\"nofollow noopener\" target=\"_blank\">ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aardvark Therapeutics a comment\u00e9 le 31 mars 2025 sur les r\u00e9sultats commerciaux du trimestre le 31 d\u00e9cembre 2024. Aardvark Therapeutics a g\u00e9n\u00e9r\u00e9 une perte de 0,40 $ par action au cours du r\u00e9cent trimestre annuel. L&#8217;ann\u00e9e pr\u00e9c\u00e9dente, il \u00e9tait de -0,100 USD par action. Le r\u00e9sultat par action a \u00e9t\u00e9 n\u00e9gatif pour l&#8217;ann\u00e9e globale. La [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1420882,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[292832,1602,65,1085,1605,62719,1603],"class_list":["post-1608361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-aardvark","tag-dernier","tag-les","tag-presente","tag-resultats","tag-therapeutics","tag-trimestre"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1608361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=1608361"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1608361\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/1420882"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=1608361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=1608361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=1608361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}